Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Butorphanol for intraoperative lung protection in patients at intermediate/high risk of postoperative pulmonary complications
ChiCTR2300073969Phase 4Recruiting
- Sponsor
- Sichuan Provincial People's Hospital
- Start
- Jan 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of butorphanol in postoperative respiratory complications (PRC) (2 arms), sponsored by Sichuan Provincial People's Hospital. Primary endpoint: Incidence of postoperative pulmonary complications. Started Jan 2022; status: recruiting.
02
Drugs
butorphanol
03
Conditions
postoperative respiratory complications (PRC)
Beyond the preview
Go deeper on ChiCTR2300073969.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300073969.